首页> 外文期刊>Pathology oncology research: POR >Frameshift Mutations of MUC15 Gene in Gastric and its Regional Heterogeneity in Gastric and Colorectal Cancers
【24h】

Frameshift Mutations of MUC15 Gene in Gastric and its Regional Heterogeneity in Gastric and Colorectal Cancers

机译:胃癌和大肠癌中MUC15基因移码突变及其区域异质性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Mucins are important in tumorigenesis and expressional alterations of mucins are common in human cancers. A membrane-bound mucin MUC15 and secreted mucins MUC4 and MUC7 are known to involve in tumorigenesis, but their mutation status in cancers remains unknown. Aim of this study was to explore whether MUC4, MUC7 and MUC15 genes are mutated and expressionally altered in gastric (GC) and colorectal cancers (CRC). In a public database, we found that MUC15 and MUC7 genes had mononucleotide repeats in the coding sequences that might be mutation targets in the cancers with microsatellite instability (MSI). We analyzed the mutations in 90 GC and 141 CRC (high MSI (MSI-H) or stable MSI/low MSI (MSS/MSI-L)) by single-strand conformation polymorphism analysis and DNA sequencing. In the present study, we found MUC15 frameshift mutations (14.7% of GC and 15.2% of CRC with MSI-H), MUC 7 frameshift mutations (2.9% of GC with MSI-H) and MUC4 frameshift mutations (8.8% of GC and 3.8% of CRC with MSI-H). These mutations were not found in in MSS/MSI-L (0/118). Additionally, we analyzed intratumoral heterogeneity (ITH) of MUC15 mutation in 16 CRC and found that seven CRC (43.8%) harbored regional ITH of MUC15. We also analyzed MUC15 expression in GC and CRC by immunohistochemistry. Negative MUC15 expression was identified in 15-41% of the GC and CRC irrespective of MSI status. Of note, the negative expression was more common in those with MUC15 mutations. We identified alterations of MUC genes at various levels (frameshift mutations, genetic ITH and expression loss), which together might play a role in tumorigenesis of GC and CRC with MSI-H. Our data suggest that mutation analysis in multiple regions is needed for a better evaluation of mutation status in CRC with MSI-H.
机译:粘蛋白在肿瘤发生中很重要,并且粘蛋白的表达改变在人类癌症中很常见。已知膜结合的粘蛋白MUC15和分泌的粘蛋白MUC4和MUC7参与肿瘤发生,但是它们在癌症中的突变状态仍然未知。这项研究的目的是探讨在胃癌(GC)和结直肠癌(CRC)中MUC4,MUC7和MUC15基因是否突变和表达改变。在一个公共数据库中,我们发现MUC15和MUC7基因在编码序列中具有单核苷酸重复,这可能是具有微卫星不稳定性(MSI)的癌症的突变靶标。我们通过单链构象多态性分析和DNA测序分析了90 GC和141 CRC(高MSI(MSI-H)或稳定MSI /低MSI(MSS / MSI-L))中的突变。在本研究中,我们发现MUC15移码突变(MSI-H占GC的14.7%,CRC的15.2%),MUC 7移码突变(MSI-H占GC的2.9%)和MUC4移码突变(GC和8.8% MSI-H的3.8%CRC)。在MSS / MSI-L(0/118)中未发现这些突变。此外,我们分析了16个CRC中MUC15突变的肿瘤内异质性(ITH),发现有七个CRC(43.8%)包含MUC15的区域ITH。我们还通过免疫组织化学分析了GC和CRC中MUC15的表达。不论MSI状态如何,GC和CRC中15-41%的MUC15表达均为阴性。值得注意的是,负表达在带有MUC15突变的患者中更为常见。我们鉴定了不同水平的MUC基因改变(移码突变,遗传ITH和表达缺失),这些改变可能在MSI-H的GC和CRC的肿瘤发生中起作用。我们的数据表明,为了更好地评估MSI-H CRC突变状态,需要在多个区域进行突变分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号